Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation

Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation

Woo Kyung Chung,1 Inseung Jeon,1 In-Jin Jang,1 Seung-Yong Seong,2 Seon Ae Han,3 Kyung-Sang Yu1 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea; 2Department of Biomedical Sciences, Seoul National University Co...

Full description

Saved in:
Bibliographic Details
Main Authors: Chung WK, Jeon I, Jang IJ, Seong SY, Han SA, Yu KS
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:Drug Design, Development and Therapy
Subjects:
phase i clinical trial
pharmacokinetics
sepsis
bild acid
Online Access:https://www.dovepress.com/safety-tolerability-and-pharmacokinetics-of-intravenous-sodium-taurode-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items